FDA
-
-
-
-
-
-
-
Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
-
-
-
-
-
-
-
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
-
-
-
-
-
-
-
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
-
-
-
-
-
-
-
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
-
-
-
-
-
-
-
Adagio Medical study results to be presented at VT symposium
-
-
-
-
-
-
-
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
-
-
-
-
-
-
-
Adagio Medical (ADGM) Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
-
323,752 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

